Isis' Cholestrol Drug Gets FDA Approval

The Carlsbad company's shares were up last week and have gone up steadily since November, gaining about 74 percent.

Carlsbad-based Isis Pharmaceuticals Inc. first company drug, Kynamro, has been given U.S. Food and Drug Administration approval to reach market.

Kynamro is an injectable drug designed to treat patients who are genetically predisposed to have high levels of LDL cholesterol, known as the “bad” cholesterol, wrote the Associated Press.

To read the full article go to: sddt.com/Finance/article.cfm?SourceCode=20130130czb&utm_medium=email&utm_source=NightlyNews&utm_campaign=2013%2D01%2D30&_t=Isis+Pharma+shares+rise+on+Kynamro+approval#.UQ_y8Y5khgM


More »
Got a question? Something on your mind? Talk to your community, directly.
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors.What's on your mind?What's on your mind?Make an announcement, speak your mind, or sell somethingPost something
See more »